Tag: Intellia
Editas, Intellia: After Massive Promote Off, Is it Time To Purchase Gene Modifying Shares?
Our indicative theme of Gene Modifying shares is down by about 24% year-to-date, in comparison with the S&P 500 which has remained nearly flat [...]
Intellia (NTLA) Miss Earnings & Revenues Estimates in This fall
Intellia Therapeutics, Inc. NTLA is a clinical-stage firm with give attention to growing gene enhancing therapies, particularly for uncommon ailmen [...]
Vertex, Intellia Therapeutics: Gene Modifying Shares To Watch
Our indicative theme of Gene Modifying Shares is up by about 187% for the reason that finish of 2018 and by about 5% year-to-date. Gene enhancing [...]
CRISPR, Editas, Intellia: Gene Modifying Shares To Play The Subsequent Revolution In Medication
Gene enhancing has emerged as a promising biotech theme. The know-how is used to insert, edit, or d [...]
6 / 6 POSTS